Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
SPOUT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GGA2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BIRC5 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
TMEM259 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
MED30 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CDK9 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Profile neighbors
ZNF830 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
IDH3B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
POC1A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SUGP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
UBIAD1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
AGFG1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FNIP1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
ARGLU1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NACC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CEP95 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on